Amgen (AMGN) EBT Margin (2009 - 2026)
Amgen (AMGN) recorded EBT Margin of 27.53% in Q2 2026, up 10.45 percentage points from 17.08% a year earlier and up 3.35 percentage points from the prior quarter.
Amgen (AMGN) EBT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Amgen's EBT Margin came in at 27.00% as of Jun 30, 2026, up 5.74 percentage points year-over-year; for FY2025, it was 24.42%, up 10.63 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -7.57 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 13.79% in FY2024 (-14.07 pp), 27.86% in FY2023 (-0.04 pp), 27.91% in FY2022 (+2.11 pp) and 25.79% in FY2021 (-6.20 pp).
- Quarterly EBT Margin has ranged from -0.91% in Q1 2024 to 56.38% in Q1 2023 over the past five years.
- On a year-over-year basis, EBT Margin rose in six of the last eight quarters, with an average year-over-year change of +7.62 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 29.53 percentage points in Q1 2023, against a drop of 57.29 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 24.18% (Q1 2026), 15.35% (Q4 2025) and 41.03% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -4.34% |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 41.75% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.53% |
| Mar 31, 2026 | 24.18% |
| Dec 31, 2025 | 15.35% |
| Sep 30, 2025 | 41.03% |
| Jun 30, 2025 | 17.08% |
| Mar 31, 2025 | 24.21% |
| Dec 31, 2024 | 8.61% |
| Sep 30, 2024 | 36.47% |
| Jun 30, 2024 | 9.47% |
| Mar 31, 2024 | -0.91% |
| Dec 31, 2023 | 10.40% |
| Sep 30, 2023 | 28.21% |
| Jun 30, 2023 | 23.10% |
| Mar 31, 2023 | 56.38% |
| Dec 31, 2022 | 25.56% |
| Sep 30, 2022 | 35.96% |
| Jun 30, 2022 | 23.22% |
| Mar 31, 2022 | 26.85% |
| Dec 31, 2021 | 31.13% |
| Sep 30, 2021 | 32.14% |
Amgen EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();